Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Protein > FGF R3 (IIIc) > FGC-H5256

Human FGF R3 (IIIc) / FGF R3C / CD333 Protein, Fc Tag (MALS verified)

Recommended Hot Products:

We offer IHC Antibody Products against multiple biomarker targets with sufficient validation, reliable quality, flexible authorization and service support!

Order Now

  • Synonym
    FGF R3 (IIIc),FGF R3C,CD333
  • Source
    Human FGF R3 (IIIc), Fc Tag(FGC-H5256) is expressed from human 293 cells (HEK293). It contains AA Glu 23 - Gly 375 (Accession # P22607-1).
    Predicted N-terminus: Glu 23
  • Molecular Characterization
    FGF R3 (IIIc) Structure

    This protein carries a human IgG1 Fc tag at the C-terminus.

    The protein has a calculated MW of 64.6 kDa. The protein migrates as 80-90 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin
    Less than 1.0 EU per μg by the LAL method.
  • Purity

    >95% as determined by SDS-PAGE.

    >90% as determined by SEC-MALS.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 100 mM Glycine, 25 mM Arginine, 150 mM NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
SDS-PAGE
FGF R3 (IIIc) SDS-PAGE

Human FGF R3 (IIIc), Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.

SEC-MALS
FGF R3 (IIIc) MALS images

The purity of Human FGF R3 (IIIc), Fc Tag (Cat. No. FGC-H5256) is more than 90% and the molecular weight of this protein is around 148-180 kDa verified by SEC-MALS.

Bioactivity-ELISA
 FGF R3 (IIIc) ELISA

Immobilized Human FGF basic, premium grade (Cat. No. BFF-H4117) at 5 μg/mL (100 μL/well) can bind Human FGF R3 (IIIc), Fc Tag (Cat. No. FGC-H5256) with a linear range of 1-39 ng/mL (QC tested).

 FGF R3 (IIIc) ELISA

Immobilized Biotinylated Human FGF basic, Avitag,His Tag (Cat. No. FGC-H81E3) at 1 μg/mL (100 μL/well) on streptavidin (Cat. No. STN-N5116) precoated (0.5 μg/well) plate can bind Human FGF R3 (IIIc), Fc Tag (Cat. No. FGC-H5256) with a linear range of 2-39 ng/mL (Routinely tested).

Bioactivity-SPR
 FGF R3 (IIIc) SPR

Human FGF R3 (IIIc), Fc Tag immobilized (Cat. No. FGC-H5256) on CM5 Chip can bind Human FGF acidic, Tag Free (Cat. No. AFF-H4116) with an affinity constant of 0.44 μM as determined in a SPR assay (Biacore 8K) (Routinely tested).

 FGF R3 (IIIc) SPR

Human FGF R3 (IIIc), Fc Tag (Cat. No. FGC-H5256) immobilized on CM5 Chip can bind Human FGF-9, Fc Tag (Cat. No. FG9-H4267) with an affinity constant of 10.5 nM as determined in a SPR assay (Biacore 8K) (Routinely tested).

  • Background
    Fibroblast growth factor receptors (FGFR) are transmembrane kinase proteins with growing importance in cancer biology given the frequency of molecular alterations and vast interface with multiple other signaling pathways. The FGFR3 gene is at the human chromosomal locus 4p16.3 also encodes two isoforms: FGF R3 (IIIb) FGF R3 (IIIc). Upregulated expression of FGFR3 protein is also found in a significant number of tumors. Additionally, FGFR3 has been found to trigger resistance to tamoxifen via the activation of the PLCγ signaling cascade.
  • Clinical and Translational Updates

Comments (0)


ETD of in-stock products: 2 business days

Price(USD) : $350.00

Price(USD) : $2540.00

Promotion & Exhibitions



Drug Development Status

  • Number of Launched Drugs:7 Details
  • Number of Drugs in Clinical Trials:30 Details
  • Latest Research Phase:Approved

Datasheet & Documentation

Request for DMF
DMF (Drug Master File)

Related Products

New Product Launch

Questions & Comments

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message